Clive MeanwellChief Executive Officer at The Medicines Company
Dr. Meanwell is the Chief Executive Officer of The Medicines Company, a New Jersey company which he founded in 1997 while a Managing Partner and Senior Managing Director at MPM Capital in Cambridge, Massachusetts. He is also Vice Chairman of BB Biotech and had been a director of the listed, Swiss corporation which invests in the field of biotechnology since 2003. Previously, Dr. Meanwell was Senior Vice President of Roche Life Sciences, Palo Alto and before then held a series of leadership positions in product development, regulatory affairs and marketing at Roche, mostly based in Switzerland. Earlier in his career he was a member of the Amgen-Roche team that developed and launched Neupogen®. Before joining the biopharmaceutical industry, Dr. Meanwell trained in medicine and then undertook a research fellowship in medical oncology at the University of Birmingham, and the Queen Elizabeth Medical Center, in the United Kingdom.